Your browser doesn't support javascript.
SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experience.
Willems, Laurent M; Balcik, Yunus; Noda, Anna H; Siebenbrodt, Kai; Leimeister, Sina; McCoy, Jeannie; Kienitz, Ricardo; Kiyose, Makoto; Reinecke, Raphael; Schäfer, Jan-Hendrik; Zöllner, Johann Philipp; Bauer, Sebastian; Rosenow, Felix; Strzelczyk, Adam.
  • Willems LM; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Balcik Y; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Noda AH; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Siebenbrodt K; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Leimeister S; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • McCoy J; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Kienitz R; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Kiyose M; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Reinecke R; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Schäfer JH; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Zöllner JP; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Bauer S; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Rosenow F; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Strzelczyk A; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, University Hospital and Goethe University Frankfurt, Frankfurt am Main, Germany; LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany. Electronic address: strz
Epilepsy Behav ; 112: 107483, 2020 11.
Article in English | MEDLINE | ID: covidwho-817039
ABSTRACT

INTRODUCTION:

When the SARS-CoV-2 pandemic reached Europe in 2020, a German governmental order forced clinics to immediately suspend elective care, causing a problem for patients with chronic illnesses such as epilepsy. Here, we report the experience of one clinic that converted its outpatient care from personal appointments to telemedicine services.

METHODS:

Documentations of telephone contacts and telemedicine consultations at the Epilepsy Center Frankfurt Rhine-Main were recorded in detail between March and May 2020 and analyzed for acceptance, feasibility, and satisfaction of the conversion from personal to telemedicine appointments from both patients' and medical professionals' perspectives.

RESULTS:

Telephone contacts for 272 patients (mean age 38.7 years, range 17-79 years, 55.5% female) were analyzed. Patient-rated medical needs were either very urgent (6.6%, n = 18), urgent (23.5%, n = 64), less urgent (29.8%, n = 81), or nonurgent (39.3%, n = 107). Outpatient service cancelations resulted in a lack of understanding (9.6%, n = 26) or anger and aggression (2.9%, n = 8) in a minority of patients, while 88.6% (n = 241) reacted with understanding, or relief (3.3%, n = 9). Telemedicine consultations rather than a postponed face-to-face visit were requested by 109 patients (40.1%), and these requests were significantly associated with subjective threat by SARS-CoV-2 (p = 0.004), urgent or very urgent medical needs (p = 0.004), and female gender (p = 0.024). Telemedicine satisfaction by patients and physicians was high. Overall, 9.2% (n = 10) of patients reported general supply problems due to SARS-CoV-2, and 28.4% (n = 31) reported epilepsy-specific problems, most frequently related to prescriptions, or supply problems for antiseizure drugs (ASDs; 22.9%, n = 25).

CONCLUSION:

Understanding and acceptance of elective ambulatory visit cancelations and the conversion to telemedicine consultations was high during the coronavirus disease 2019 (COVID-19) lockdown. Patients who engaged in telemedicine consultations were highly satisfied, supporting the feasibility and potential of telemedicine during the COVID-19 pandemic and beyond.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Infection Control / Telemedicine / Coronavirus Infections / Epilepsy / Pandemics / Ambulatory Care / Ambulatory Care Facilities Type of study: Observational study Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Epilepsy Behav Journal subject: Behavioral Sciences / Neurology Year: 2020 Document Type: Article Affiliation country: J.yebeh.2020.107483

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Infection Control / Telemedicine / Coronavirus Infections / Epilepsy / Pandemics / Ambulatory Care / Ambulatory Care Facilities Type of study: Observational study Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Epilepsy Behav Journal subject: Behavioral Sciences / Neurology Year: 2020 Document Type: Article Affiliation country: J.yebeh.2020.107483